These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33141473)

  • 1. Synthesis and in vitro antileishmanial efficacy of benzyl analogues of nifuroxazide.
    Kannigadu C; Aucamp J; N'Da DD
    Drug Dev Res; 2021 Apr; 82(2):287-295. PubMed ID: 33141473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing O-substituted nifuroxazide analogues against Leishmania: Synthesis, in vitro efficacy, and hit/lead identification.
    Badenhorst GD; Kannigadu C; Aucamp J; N'Da DD
    Eur J Pharm Sci; 2022 Sep; 176():106242. PubMed ID: 35732232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro antileishmanial efficacy of novel benzothiadiazine-1,1-dioxide derivatives.
    Mangwegape DK; Zuma NH; Aucamp J; N'Da DD
    Arch Pharm (Weinheim); 2021 May; 354(5):e2000280. PubMed ID: 33491807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and in vitro antileishmanial efficacy of novel quinazolinone derivatives.
    Prinsloo IF; Zuma NH; Aucamp J; N'Da DD
    Chem Biol Drug Des; 2021 Feb; 97(2):383-398. PubMed ID: 32914553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro antileishmanial activity of alkylene-linked nitrofurantoin-triazole hybrids.
    Zuma NH; Aucamp J; Janse van Rensburg HD; N'Da DD
    Eur J Med Chem; 2023 Jan; 246():115012. PubMed ID: 36516584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer-aided discovery of two novel chalcone-like compounds active and selective against Leishmania infantum.
    Gomes MN; Alcântara LM; Neves BJ; Melo-Filho CC; Freitas-Junior LH; Moraes CB; Ma R; Franzblau SG; Muratov E; Andrade CH
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2459-2464. PubMed ID: 28434763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, antileishmanial, and antifungal biological evaluation of novel 3,5-disubstituted isoxazole compounds based on 5-nitrofuran scaffolds.
    Trefzger OS; Barbosa NV; Scapolatempo RL; das Neves AR; Ortale MLFS; Carvalho DB; Honorato AM; Fragoso MR; Shuiguemoto CYK; Perdomo RT; Matos MFC; Chang MR; Arruda CCP; Baroni ACM
    Arch Pharm (Weinheim); 2020 Feb; 353(2):e1900241. PubMed ID: 31840866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of Thiocarbohydrazones and Evaluation of their in vitro Antileishmanial Activity.
    Muhammad MT; Ghouri N; Khan KM; Arshia ; Choudhary MI; Perveen S
    Med Chem; 2018; 14(7):725-732. PubMed ID: 29332596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Antileishmanial and Antischistosomal Activities of Anemonin Isolated from the Fresh Leaves of
    Sirak B; Asres K; Hailu A; Dube M; Arnold N; Häberli C; Keiser J; Imming P
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of ethylene glycol linked nitrofurantoin derivatives against Leishmania: Synthesis and in vitro activity.
    Ndlovu K; Kannigadu C; Aucamp J; van Rensburg HDJ; N'Da DD
    Arch Pharm (Weinheim); 2023 May; 356(5):e2200529. PubMed ID: 36759973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of marine alkaloid: 8,9-dihydrocoscinamide B and its analogues as Novel class of antileishmanial agents.
    Gupta L; Talwar A; Nishi ; Palne S; Gupta S; Chauhan PM
    Bioorg Med Chem Lett; 2007 Jul; 17(14):4075-9. PubMed ID: 17548194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of trifluralin analogues as antileishmanial agents.
    Esteves MA; Fragiadaki I; Lopes R; Scoulica E; Cruz ME
    Bioorg Med Chem; 2010 Jan; 18(1):274-81. PubMed ID: 19926293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the in vitro antileishmanial activities of bioactive guided fractionations of two medicinal plants.
    Al Nasr IS
    Trop Biomed; 2020 Mar; 37(1):15-23. PubMed ID: 33612714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and comparison of in vitro dual anti-infective activities of novel naphthoquinone hybrids and atovaquone.
    Erasmus C; Aucamp J; Smit FJ; Seldon R; Jordaan A; Warner DF; N'Da DD
    Bioorg Chem; 2021 Sep; 114():105118. PubMed ID: 34216896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antileishmanial activity of 2-amino-thiophene derivative SB-200.
    Sousa JPA; Sousa JMS; Rodrigues RRL; Nunes TAL; Machado YAA; Araujo AC; da Silva IGM; Barros-Cordeiro KB; Báo SN; Alves MMM; Mendonça-Junior FJB; Rodrigues KADF
    Int Immunopharmacol; 2023 Oct; 123():110750. PubMed ID: 37536181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of oral drugs against Leishmania tropica in human macrophages in vitro.
    Berman JD; Lee LS
    Am J Trop Med Hyg; 1983 Sep; 32(5):947-51. PubMed ID: 6312823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of synthetic peptides RP-1 and AA-RP-1 against Leishmania species in vitro and in vivo.
    Erfe MC; David CV; Huang C; Lu V; Maretti-Mira AC; Haskell J; Bruhn KW; Yeaman MR; Craft N
    Antimicrob Agents Chemother; 2012 Feb; 56(2):658-65. PubMed ID: 22123683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzimidazole derivatives endowed with potent antileishmanial activity.
    Tonelli M; Gabriele E; Piazza F; Basilico N; Parapini S; Tasso B; Loddo R; Sparatore F; Sparatore A
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):210-226. PubMed ID: 29233048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo efficacy of ether lipid edelfosine against Leishmania spp. and SbV-resistant parasites.
    Varela-M RE; Villa-Pulgarin JA; Yepes E; Müller I; Modolell M; Muñoz DL; Robledo SM; Muskus CE; López-Abán J; Muro A; Vélez ID; Mollinedo F
    PLoS Negl Trop Dis; 2012; 6(4):e1612. PubMed ID: 22506086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antileishmanial activity of 4-phenyl-1-[2-(phthalimido-2-yl)ethyl]-1H-1,2,3-triazole (PT4) derivative on Leishmania amazonensis and Leishmania braziliensis: In silico ADMET, in vitro activity, docking and molecular dynamic simulations.
    Holanda VN; Silva WVD; Nascimento PHD; Silva SRB; Cabral Filho PE; Assis SPO; Silva CAD; Oliveira RN; Figueiredo RCBQ; Lima VLM
    Bioorg Chem; 2020 Dec; 105():104437. PubMed ID: 33339081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.